Coronary artery bypass grafting versus Drug eluting Stents in patients with End stage renal disease

This article compares clinical adverse events after percutaneous intervention with drug‐eluting stents (DESs) and coronary artery bypass grafting (CABG) in patients with ESRD.  Early mortality is lower with DESs compared with coronary artery bypass in patients with ESRD. Rate of reintervention is significantly higher in the DES cohort. At a mean pooled follow‐up of two years, both mortality and MACCE are comparable in both cohorts.